Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
29.42
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
99
100
Next >
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Via
Benzinga
European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
February 19, 2024
From
Pfizer Inc.
Via
Business Wire
7 Blue-Chip Stocks to Pick Up While They’re Down
February 18, 2024
Build a robust investment portfolio and make the most of the discount with these blue-chip stocks to buy and hold.
Via
InvestorPlace
ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
February 18, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Behind the Scenes of Pfizer's Latest Options Trends
February 13, 2024
Via
Benzinga
ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
February 18, 2024
WHY: NEW YORK, NY - (NewMediaWire) - February 18, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 17, 2024
Patience will be rewarded with these stocks.
Via
The Motley Fool
MarketBeat Week in Review – 2/12 - 2/16
February 17, 2024
Higher inflation readings dampened expectations for rate cuts, and a shortened trading week may get more volatile when many retail stocks report earnings
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Pfizer's Expansion Sparks Boom for these Healthcare REITs
February 16, 2024
Via
Benzinga
7 F-Rated Stocks to Sell for February 2024
February 16, 2024
The stock market is off to a good start and there are plenty of great names out there. So don't hold on to your F-rated stocks to sell.
Via
InvestorPlace
Pfizer's Mixed Bag: A Look At The Fourth Quarter 2023 Earnings Call - Main Takeaways
February 15, 2024
Pfizer Inc. (NYSE: PFE) recently held its fourth-quarter earnings call, revealing a year of contrasts for the pharmaceutical giant. While the company faced setbacks, particularly with its COVID-19...
Via
Benzinga
Topics
Earnings
Exposures
COVID-19
Financial
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.
Via
InvestorPlace
Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day
February 15, 2024
From
Pfizer Inc.
Via
Business Wire
The 7 Best Dividend Stocks to Buy in February 2024
February 15, 2024
The market is soaring and many sectors appear overvalued. Fortunately, these leading dividend stocks are still available at great prices.
Via
InvestorPlace
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Pfizer at 10-year support: Is it a massive buy opportunity?
February 15, 2024
As Pfizer's stock nears 10-year support at $26, with better-than-expected earnings despite declining COVID-19-related revenue, is now the time to buy?
Via
MarketBeat
Topics
Earnings
Exposures
COVID-19
Financial
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
From
FN Media Group LLC
Via
GlobeNewswire
7 Undervalued Dividend Stocks to Buy in February for High Total Returns
February 15, 2024
The undervalued dividend stocks could see serious growth before too long. Plus, they pay you to hold them while you wait.
Via
InvestorPlace
Pfizer Agrees To Pay $93M To Settle Lipitor Antitrust Lawsuit Despite Calling Allegations 'Factually And Legally Without Merit'
February 15, 2024
Pfizer has agreed to pay $93 million to settle an antitrust lawsuit related to its cholesterol drug Lipitor.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Biden Boom: 7 Stocks to Buy if Democrats Win the Election in 2024
February 14, 2024
Election-proof your portfolio: these seven stocks could deliver significant gains if Biden wins the election in 2024.
Via
InvestorPlace
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
February 14, 2024
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.
Via
InvestorPlace
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
February 14, 2024
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
February 14, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NYSE:PFE),(NASDAQ:BTAI),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
February 14, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
February 14, 2024
From
FN Media Group LLC
Via
GlobeNewswire
7 High-Yield Dividend Stocks for the Ultimate Retirement Portfolio
February 13, 2024
Discover seven high-yield dividend stocks for retirement across diverse sectors, including telecommunications, REITs, and pharmaceuticals.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
3 Blue-Chip Stocks Drowning in Earnings Despair
February 13, 2024
Investors should shy away from these companies after they delivered substandard financial results for the final months of last year.
Via
InvestorPlace
The 3 Best Biotech Stocks to Buy in February 2024
February 13, 2024
The best biotech stocks to buy offer consistent growth opportunities and resist the influence of singular drug successes.
Via
InvestorPlace
Contrarian Plays: 3 Stocks Going Against the Grain That Could Deliver Huge Gains
February 13, 2024
The conventional wisdom is that these stocks are going nowhere. But the conventional wisdom just might be wrong.
Via
The Motley Fool
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.